On a global scale, FIGO stage, tumor size, LVSI, and myometrial invasion emerged as the primary contributors by mean SHAP (Fig. 5A). Conversely, CA125 and peritoneal cytology were associated with increased risk, while progesterone receptor (PR) > 10 % shifted predictions towards No Relapse (Fig. 5B). In terms of class-specific SHAP, Early Relapse was associated with higher stage, positive cytology, and elevated CA125 levels. The gene discussed is PGR; the disease is neoplasm.